Skip to main content

Table 1 Baseline characteristics of participants

From: Development and validation of a new nomogram to screen for MAFLD

 

Overall (n = 7300)

Non-MAFLD (n = 3971)

MAFLD (n = 3329)

P value

Age (years)

48.89 ± 18.06

46.18 ± 18.87

52.13 ± 16.47

 < 0.001

Sex, n (%)

   

 < 0.001

Female

3685 (50.48)

2180 (54.90)

1505 (45.21)

 

Male

3615 (49.52)

1791 (45.10)

1824 (54.79)

 

Race, n (%)

   

 < 0.001

Non-Hispanic Black

1817 (24.89)

1113 (28.03)

704 (21.15)

 

Non-Hispanic White

2563 (35.11)

1343 (33.82)

1220 (36.65)

 

Other Hispanic

763 (10.45)

405 (10.20)

358 (10.75)

 

Non-Hispanic Asian

884 (12.11)

544 (13.70)

340 (10.21)

 

Mexican American

918 (12.58)

367 (9.24)

551 (16.55)

 

Other

355 (4.86)

199 (5.01)

156 (4.69)

 

AC (cm)

33.54 ± 5.24

31.39 ± 4.47

36.11 ± 4.92

 < 0.001

HC (cm)

106.86 ± 14.15

101.54 ± 11.50

113.22 ± 14.40

 < 0.001

WC (cm)

100.07 ± 16.96

91.66 ± 13.79

110.09 ± 14.79

 < 0.001

BMI (kg/m2)

29.63 ± 7.05

26.48 ± 5.52

33.40 ± 6.84

 < 0.001

WBC (× 109/l)

7.21 ± 5.14

6.92 ± 6.67

7.55 ± 2.16

 < 0.001

LYM (× 109/l)

2.25 ± 4.33

2.21 ± 5.81

2.31 ± 0.88

0.314

NEU (× 109/l)

4.15 ± 1.69

3.94 ± 1.69

4.39 ± 1.64

 < 0.001

HB (g/l)

14.03 ± 1.54

13.86 ± 1.51

14.24 ± 1.55

 < 0.001

PLT (× 109/l)

246.47 ± 64.89

243.89 ± 63.93

249.55 ± 65.89

 < 0.001

FPG (mmol/l)

5.62 ± 1.95

5.22 ± 1.36

6.10 ± 2.39

 < 0.001

TG (mmol/l)

1.54 ± 1.12

1.24 ± 0.79

1.91 ± 1.34

 < 0.001

TyG

8.64 ± 0.65

8.40 ± 0.55

8.93 ± 0.65

 < 0.001

ALT (u/l)

22.32 ± 18.99

18.97 ± 18.59

26.32 ± 18.69

 < 0.001

AST (u/l)

21.89 ± 14.42

21.11 ± 15.15

22.82 ± 13.44

 < 0.001

ALT/AST ratio

0.99 ± 0.36

0.88 ± 0.29

1.13 ± 0.38

 < 0.001

TC (mmol/l)

4.79 ± 1.05

4.72 ± 1.03

4.87 ± 1.06

 < 0.001

HDL-C (mmol/l)

1.38 ± 0.40

1.48 ± 0.41

1.25 ± 0.36

 < 0.001

GGT (u/l)

31.60 ± 51.68

26.59 ± 54.93

37.59 ± 46.81

 < 0.001

ALP (u/l)

77.71 ± 25.80

74.75 ± 25.81

81.23 ± 25.33

 < 0.001

ALB (g/l)

40.79 ± 3.34

41.08 ± 3.37

40.44 ± 3.28

 < 0.001

GLB (g/l)

30.88 ± 4.32

30.60 ± 4.35

31.21 ± 4.25

 < 0.001

TP (g/l)

71.67 ± 4.42

71.68 ± 4.49

71.66 ± 4.34

0.796

TBIL (mg/dl)

7.85 ± 4.74

8.06 ± 5.04

7.60 ± 4.35

 < 0.001

hsCRP (mg/l)

3.92 ± 8.30

3.03 ± 7.19

4.98 ± 9.34

 < 0.001

CRE (mg/dl)

79.03 ± 39.21

78.34 ± 36.05

79.86 ± 42.67

0.100

BUN (mg/dl)

5.25 ± 2.02

5.12 ± 1.91

5.40 ± 2.13

 < 0.001

eGFR (mg/min/1.73m2)

95.59 ± 23.59

97.60 ± 23.75

93.20 ± 23.18

 < 0.001

Hypertension, n (%)

   

 < 0.001

No

4662 (63.86)

2889 (72.75)

1773 (53.26)

 

Yes

2638 (36.14)

1082 (27.25)

1556 (46.74)

 

Diabetes, n (%)

   

 < 0.001

No

5895 (80.75)

3574 (90.00)

2321 (69.72)

 

Yes

1405 (19.25)

397 (10.00)

1008 (30.28)

 

Smoking, n (%)

   

 < 0.001

Never

4367 (59.82)

2469 (62.18)

1898 (57.01)

 

Former

1654 (22.66)

750 (18.89)

904 (27.16)

 

Current

1279 (17.52)

752 (18.94)

527 (15.83)

 

FLI

55.25 ± 32.65

37.28 ± 28.96

76.68 ± 22.19

 < 0.001

HSI

38.97 ± 8.52

34.82 ± 6.60

43.92 ± 7.88

 < 0.001

VAI

2.17 ± 2.26

1.58 ± 1.61

2.88 ± 2.67

 < 0.001

FSI

-0.89 ± 1.87

-1.88 ± 1.42

0.28 ± 1.66

 < 0.001

ZJU

40.79 ± 8.34

36.68 ± 6.38

45.69 ± 7.73

 < 0.001

  1. Data are presented as means ± SD and absolute or relative percentages